Takuya Hara Selected Research

Takuya Hara Research Topics

5	Esophageal and Gastric Varices (Esophageal Varices) 03/2024 - 11/2012
4	Neoplasms (Cancer) 06/2019 - 09/2009
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 12/2019
1	Varicose Veins (Varicose Vein) 03/2024
1	Consciousness Disorders 01/2023
1	Brain Injuries (Brain Injury) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Ascites 01/2023
1	Hydrothorax 01/2023
1	End Stage Liver Disease 01/2023
1	Lung Diseases (Lung Disease) 01/2022
1	Lymphocele 11/2021
1	Hemorrhage 03/2021
1	Cysts 07/2019
1	Sarcoma (Soft Tissue Sarcoma) 06/2019
1	Cardiac Tamponade 11/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 07/2017
1	Fever (Fevers) 07/2017
1	Hand Injuries (Hand Injury) 10/2012
1	Ischemia 03/2012
1	Intermittent Claudication 03/2012
1	Necrosis 03/2012
1	Vascular System Injuries 03/2012
1	Peripheral Arterial Disease 03/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2009
1	Lymphoma (Lymphomas) 09/2009
1	Infections 04/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2008
1	Hepatoblastoma 04/2008
1	Acute Myelomonocytic Leukemia 04/2008
1	Inflammation (Inflammations) 05/2005

3	Sclerosing Solutions (Sclerosing Agents)IBA 12/2019 - 11/2012
2	EnbucrilateIBA 03/2024 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 12/2019
2	NivolumabIBA 10/2018 - 01/2018
2	Immune Checkpoint InhibitorsIBA 10/2018 - 01/2018
1	DiureticsIBA 01/2023
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	SodiumIBA 01/2023
1	Tolvaptan FDA Link 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2017
1	Clarithromycin (Biaxin)FDA LinkGeneric 07/2017
1	Contrast MediaIBA 11/2012
1	Carbon DioxideIBA 11/2012
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2012
1	Messenger RNA (mRNA)IBA 10/2012
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 03/2012
1	Cilostazol (Pletal)FDA LinkGeneric 03/2012
1	Phosphodiesterase 3 InhibitorsIBA 03/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2008
1	Proteinase-Activated ReceptorsIBA 05/2005

3	Therapeutics 01/2023 - 09/2009
2	Catheters 10/2022 - 06/2019
2	Sclerotherapy 07/2019 - 11/2012
2	Drug Therapy (Chemotherapy) 10/2018 - 04/2008
2	Oral Administration 03/2012 - 04/2008
1	Stents 03/2024
1	Transjugular Intrahepatic Portasystemic Shunt 01/2023
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2023
1	Duration of Therapy 11/2021
1	Conservative Treatment 03/2021
1	Vena Cava Filters (Inferior Vena Cava Filter) 11/2018
1	Hematopoietic Stem Cell Transplantation 09/2009